≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Malignant neoplasm of heart, mediastinum and pleura

DOID Endpoint Browser

C3_HEART_MEDIASTINUM_PLEURA

Heart neoplasm: Tumors in any part of the heart. They include primary cardiac tumors and metastatic tumors to the heart. Their interference with normal cardiac functions can cause a wide variety of symptoms including HEART FAILURE; CARDIAC ARRHYTHMIAS; or EMBOLISM.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C38
  • Cause of death: ICD-9 — 16[3-4]
  • Cause of death: ICD-8 — 163[0-1]
  • Cause of death: excluded ICD-9 — 1640
  • Cancer registry: Topography ICD-O-3 — C38
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

477

4. Check minimum number of events

None

477

5. Include endpoints

None

477

6. Filter based on genotype QC (FinnGen only)

466

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 466 126 340
Unadjusted period prevalence (%) 0.13 0.04 0.16
Median age at first event (years) 69.51 62.48 72.11

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
477
Matched controls
4770
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
182.5
307.7
213
21
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
79.7
307.7
250
65
C45.0
ICD-10 Finland
Mesothelioma of pleura
+∞
307.7
294
*
A04AA01
ATC
ondansetron; systemic, rectal
76.8
283.0
156
30
130
Kela drug reimbursment
Malignant tumour
+∞
279.6
240
*
A03FA01
ATC
metoclopramide; systemic, rectal
21.1
257.9
264
265
Z51.5
ICD-10 Finland
Palliative care
30.2
218.5
158
77
N02AA05
ATC
oxycodone; systemic
14.1
195.7
269
400
J94.8
ICD-10 Finland
Other specified pleural conditions
46.1
173.0
105
29
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
26.0
168.5
126
65
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
46.1
168.2
102
28
JN4BD
NOMESCO Finland
Extensive body CT
18.7
162.7
146
110
9050/3-C38.4
ICD-O-3
Mesothelioma, malignant of pleura, NOS
+∞
156.0
141
*
TGA30
NOMESCO Finland
Thoracocentesis
79.1
126.3
68
10
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
31.1
125.5
85
33
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
27.0
119.1
85
38
9052/3-C38.4
ICD-O-3
Epithelioid mesothelioma, malignant of pleura, NOS
+∞
118.8
109
*
GAC01
NOMESCO Finland
Endoscopic biopsy of pleura
1323.7
111.1
104
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
44.1
107.4
65
17
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1243.3
105.5
99
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
8.9
96.0
144
220
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
12.9
93.4
99
95
WX302
NOMESCO Finland
Thoracal epidural anesthesy
21.7
85.5
66
35
JN4AD
NOMESCO Finland
Body CT examination
9.9
77.6
100
125
UGC12
NOMESCO Finland
Flexible bronchoscopy
8.2
72.3
111
171
A04AA02
ATC
granisetron; systemic, transdermal
761.4
68.8
66
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
643.0
59.0
57
*
L03AA02
ATC
filgrastim; parenteral
630.1
57.9
56
*
GD1AD
NOMESCO Finland
Thorax CT examination
8.6
57.8
81
111
GAC00
NOMESCO Finland
Biopsy of pleura
167.8
57.3
59
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
14.8
57.1
53
40
C38.4
ICD-10 Finland
Malignant neoplasm: Pleura
+∞
56.4
53
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
210.9
55.2
56
*
ZX120
NOMESCO Finland
Intravenous
7.1
54.5
92
155
L03AA13
ATC
pegfilgrastim; parenteral
206.7
54.2
55
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
52.0
49
*
L01CA04
ATC
vinorelbine; systemic
+∞
52.0
49
*
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
194.0
51.0
52
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
45.6
43
*
XX3DW
NOMESCO Finland
Time consuming IT work
8.1
44.3
64
90
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.7
41.7
304
1541
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
157.1
41.5
43
*
WZC30
NOMESCO Finland
Teaching
4.7
39.6
107
274
WW500
NOMESCO Finland
Blood transfusion
10.9
38.6
43
43
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.8
38.1
157
547
9051/3-C38.4
ICD-O-3
Fibrous mesothelioma, malignant of pleura, NOS
+∞
38.0
36
*
1BA04, ,
NOMESCO Finland
+∞
38.0
36
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
37.0
35
*
C45.9
ICD-10 Finland
Mesothelioma, unspecified
+∞
37.0
35
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.5
36.6
176
676
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
35.9
34
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
55.8
35.0
41
8
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
+∞
34.8
33
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
361.7
34.4
34
*
J94.9
ICD-10 Finland
Pleural condition, unspecified
44.7
33.7
41
10
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
350.1
33.3
33
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
182.6
33.2
34
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
10.7
31.3
35
35
JN4CD
NOMESCO Finland
Very extensive body CT
12.7
31.0
31
26
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
30.5
29
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
30.5
29
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.7
29.6
59
115
A06AH03
ATC
naloxegol; oral
60.8
29.5
34
6
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
110.3
29.0
31
*
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
+∞
28.4
27
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
28.4
27
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.8
28.2
99
304
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
+∞
27.4
26
*
WF002
NOMESCO Finland
Radical radiotherapy
80.0
27.1
30
*
J01MA14
ATC
moxifloxacin; systemic
4.1
26.3
81
226
TK800
NOMESCO Finland
Hemodialysis
9.0
26.1
33
39
GAA31
NOMESCO Finland
Thoracoscopy
274.7
26.0
26
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
274.7
26.0
26
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
25.2
24
*
R84
ICPC
Malignant neoplasm bronchus/lung
263.2
24.9
25
*
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
6.5
24.6
42
70
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
23.2
144
620
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
23.1
22
*
9679/3-C38.3
ICD-O-3
Mediastinal large B-cell lymphoma of mediastinum, NOS
+∞
23.1
22
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
9.2
22.6
28
32
J01MA12
ATC
levofloxacin; systemic
2.9
22.6
132
549
A04AD12
ATC
aprepitant; systemic
+∞
22.0
21
*
C38.3
ICD-10 Finland
Malignant neoplasm: Mediastinum, part unspecified
+∞
22.0
21
*
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
22.0
21.5
31
15
ZX090
NOMESCO Finland
Other technic of radiotherapy
80.5
20.9
23
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
20.5
196
1037
B03BA03
ATC
hydroxocobalamin; parenteral
4.0
20.2
63
176
H02AB06
ATC
prednisolone; systemic
2.4
20.0
260
1574
AA1BD
NOMESCO Finland
Extensive CT of head and brain
8.5
19.8
26
32
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
109.6
19.7
21
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
19.4
135
610
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
57.5
19.1
22
*
9053/3-C38.4
ICD-O-3
Mesothelioma, biphasic, malignant of pleura, NOS
+∞
18.9
18
*
A79
ICPC
Malignancy NOS
+∞
18.9
18
*
116
Kela drug reimbursment
Prostate cancer
+∞
18.9
18
*
WX600
NOMESCO Finland
Single shot through catheter
24.9
18.8
26
11
N02AA01
ATC
morphine; systemic, rectal
15.9
18.7
30
20
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
15.9
18.7
30
20
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
16.2
18.2
29
19
8000/3-C38.4
ICD-O-3
Neoplasm, malignant of pleura, NOS
+∞
17.8
17
*
9663/3-C38.3
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of mediastinum, NOS
+∞
17.8
17
*
B01AB10
ATC
tinzaparin; parenteral
3.9
17.2
55
156
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
16.8
16
*
R85
ICPC
Malignant neopl respiratory other
+∞
16.8
16
*
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
+∞
16.8
16
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
93.4
16.7
18
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
175.9
16.6
17
*
C45.1
ICD-10 Finland
Mesothelioma of peritoneum
+∞
15.7
15
*
9680/3-C38.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of mediastinum, NOS
+∞
15.7
15
*
GDD20
NOMESCO Finland
Extended pneumonectomy
+∞
15.7
15
*
JN6AD
NOMESCO Finland
CT of torso and neck
23.0
15.7
22
10
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
88.0
15.7
17
*
R06.0
ICD-10 Finland
Dyspnoea
2.3
15.6
170
930
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.5
15.4
56
173
Z2446
NOMESCO Finland
Social worker
3.9
15.2
47
130
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
46.6
15.2
18
*
L02AE02
ATC
leuprorelin; implant, parenteral
58.6
14.9
17
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.0
14.7
44
119
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
14.7
14
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
14.7
14
*
R82
ICPC
Pleurisy/pleural effusion
82.7
14.7
16
*
QBC00
NOMESCO Finland
Removal of foreign body from skin of trunk or subcutaneous tissue
154.5
14.5
15
*
R4110
NOMESCO Finland
Physiotherapy
2.3
14.4
143
748
N03AX16
ATC
[U] pregabalin
2.4
14.1
119
580
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
13.6
13
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
13.6
13
*
C45
ICD-10 Finland
Mesothelioma
+∞
13.6
13
*
GAC43
NOMESCO Finland
Total decortication of pleura
143.9
13.5
14
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
13.1
70
272
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.4
12.6
21
34
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
12.6
12
*
GAC30
NOMESCO Finland
Artificial pneumothorax
+∞
12.6
12
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
25.1
12.5
17
7
B01AB05
ATC
enoxaparin; parenteral
2.1
12.5
154
873
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
12.1
189
1167
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
66.6
11.7
13
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
66.6
11.7
13
*
WW200
NOMESCO Finland
Immunization
5.4
11.6
23
44
J86.9
ICD-10 Finland
Pyothorax without fistula
11.5
11.6
21
19
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
11.5
11
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
11.5
11
*
GDD96
NOMESCO Finland
Other pneumonectomy
+∞
11.5
11
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
11.5
11
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
11.5
11
*
GEA00
NOMESCO Finland
Mediastinoscopy
36.0
11.3
14
*
SPAT1109
SPAT
Analgesia with portable analgesic pump
36.0
11.3
14
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.8
11.3
26
57
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
11.1
75
328
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
11.0
172
1054
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
28.8
10.8
14
5
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
22.1
10.7
15
7
R50.9
ICD-10 Finland
Fever, unspecified
2.4
10.7
81
373
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
112.4
10.5
11
*
PJA12
NOMESCO Finland
Sentinel node biopsy
112.4
10.5
11
*
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
10.5
10
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
10.5
10
*
C38.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of heart, mediastinum and pleura
+∞
10.5
10
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.5
10
*
L02BB03
ATC
bicalutamide; oral
+∞
10.5
10
*
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
+∞
10.5
10
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
10.4
107
560
A02BC02
ATC
pantoprazole; systemic
1.9
10.4
304
2278
WX402
NOMESCO Finland
General anaesthesia
2.4
10.3
82
385
ZX112
NOMESCO Finland
Subcutaneous
17.2
9.9
15
9
XW000
NOMESCO Finland
Bone marrow biopsy
4.1
9.9
27
68
WW200, ,
SPAT
0.2
9.8
19
698
Z2221
NOMESCO Finland
Medical doctor
2.0
9.7
129
742
ZXE00
NOMESCO Finland
One hour or less
1.9
9.7
179
1152
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
11.7
9.6
17
15
GAC37
NOMESCO Finland
Endoscopic chemical pleurodesis
102.0
9.4
10
*
1XC02, ,
NOMESCO Finland
30.7
9.4
12
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
9.4
9
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
9.4
9
*
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
9.4
9
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
9.4
9
*
L01CB01
ATC
etoposide; systemic
+∞
9.4
9
*
GA2CT
NOMESCO Finland
Pleural biopsy with CT guidance
+∞
9.4
9
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
8.9
9.4
19
22
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
9.1
81
398
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
37.4
9.1
11
*
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
5.0
8.9
19
39
N02AX02
ATC
tramadol; systemic, rectal
1.8
8.9
201
1368
ZXE40
NOMESCO Finland
More than seven and less than nine hours
6.9
8.4
20
30
D38.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thymus
91.6
8.4
9
*
GAC46
NOMESCO Finland
Partial decortication of pleura
91.6
8.4
9
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
91.6
8.4
9
*
I31.3
ICD-10 Finland
Pericardial effusion (noninflammatory)
91.6
8.4
9
*
8000/3-C38.3
ICD-O-3
Neoplasm, malignant of mediastinum, NOS
+∞
8.4
8
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
8.4
8
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
8.4
8
*
115
Kela drug reimbursment
Breast cancer
+∞
8.4
8
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
8.4
8
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
8.4
8
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
17.5
8.1
12
7
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
15.3
7.7
12
8
J93.9
ICD-10 Finland
Pneumothorax, unspecified
18.7
7.6
11
6
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.9
7.6
36
131
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
7.8
7.4
16
21
GEB30
NOMESCO Finland
Mediastinotomy and excision of lesion
81.3
7.4
8
*
Y77
ICPC
Malignant neoplasm prostate
81.3
7.4
8
*
GDC00
NOMESCO Finland
Lobectomy of lung
81.3
7.4
8
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
81.3
7.4
8
*
GAC20
NOMESCO Finland
Excision or destruction of lesion of pleura
+∞
7.3
7
*
159
Kela drug reimbursment
Pazopanib
+∞
7.3
7
*
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
7.3
7
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
7.3
7
*
C38.0
ICD-10 Finland
Malignant neoplasm: Heart
+∞
7.3
7
*
C38.2
ICD-10 Finland
Malignant neoplasm: Posterior mediastinum
+∞
7.3
7
*
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.1
7.3
*
279
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
30.5
7.2
9
*
B01AB04
ATC
dalteparin; parenteral
3.3
7.1
27
86
N06DX01
ATC
memantine; oral
0.2
7.1
7
334
Z3231
NOMESCO Finland
Registered nurse
1.8
6.9
123
769
Z31.6
ICD-10 Finland
General counselling and advice on procreation
14.0
6.9
11
8
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.9
6.9
16
24
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
6.9
57
272
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
40.6
6.8
8
*
SPAT1062
SPAT
Lung clearance therapy
22.9
6.7
9
*
M79.6
ICD-10 Finland
Pain in limb
0.5
6.5
71
1219
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
70.8
6.4
7
*
R93.8
ICD-10 Finland
Abnormal findings on diagnostic imaging of other specified body structures
70.8
6.4
7
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
70.8
6.4
7
*
XX1XW
NOMESCO Finland
Extensive written report from radiologist
5.3
6.4
18
35
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
8.3
6.4
13
16
HA1AA
NOMESCO Finland
X-ray mammography
6.1
6.4
16
27
N05CF01
ATC
zopiclone; oral
1.7
6.3
155
1058
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.0
6.3
28
98
TGC00
NOMESCO Finland
Bronchial lavation
3.9
6.3
18
47
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.2
6.3
25
82
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
9680/3-C38.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pleura, NOS
+∞
6.3
6
*
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
+∞
6.3
6
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
6.3
6
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
6.3
6
*
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
+∞
6.3
6
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
C45.7
ICD-10 Finland
Mesothelioma of other sites
+∞
6.3
6
*
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
+∞
6.3
6
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
6.3
6
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
6.3
6
*
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
+∞
6.3
6
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
6.3
6
*
R4190
NOMESCO Finland
Nutritional therapy
5.2
6.2
18
36
J93.8
ICD-10 Finland
Other pneumothorax
12.7
6.1
10
8
A10BK03
ATC
empagliflozin; oral
0.2
6.0
6
288

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
157
29
80.21
287.03
2.3
1.2
—
—
—
0
0
190
85
36.49
274.49
1.6
1.2
—
—
—
0
0
152
33
67.14
268.68
1.9
1.3
—
—
—
0
0
155
41
55.52
261.80
2.0
1.3
1842.34
2422.93
e6/l
0.38
126
30
151
37
59.25
259.62
1.9
1.4
40561.72
212628.83
e6/l
0.55
111
23
108
35
39.60
170.23
2.0
1.3
—
—
—
0
0
65
19
39.45
104.22
1.5
1.4
—
—
—
0
0
127
161
10.39
98.57
2.1
1.3
3.48
2.79
ug/l
0.29
103
114
195
512
5.75
74.20
2.4
2.0
—
—
—
0
0
178
480
5.32
64.56
5.6
2.8
0.78
0.83
mmol/l
6.89
170
443
222
932
3.59
40.91
2.8
1.6
—
—
—
0
0
231
1017
3.47
39.06
6.3
4.0
—
—
—
0
0
291
1517
3.35
36.48
8.7
5.2
9.61
8.76
%
3.76
286
1401
294
1550
3.34
36.01
8.6
5.1
20.73
25.99
%
11.91
289
1439
324
1820
3.43
35.47
18.9
5.9
4.71
4.53
e9/l
0.45
291
1576
296
1631
3.15
32.38
8.1
4.8
0.71
0.62
e9/l
4.91
256
1402
296
1636
3.13
32.10
8.1
4.8
0.04
0.04
e9/l
1.06
258
1414
298
1668
3.10
31.32
8.1
4.9
1.46
1.78
e9/l
9.52
259
1466
276
1487
3.03
30.97
9.5
5.3
—
—
—
0
0
297
1683
3.03
30.09
8.7
5.1
0.17
0.21
e9/l
2.20
261
1469
35
7
53.75
29.79
1.2
1.0
—
—
—
0
0
82
224
4.21
27.42
1.3
1.1
—
—
—
0
0
263
1448
2.82
27.21
6.9
3.8
31.21
35.22
g/l
16.68
251
1328
288
1687
2.78
25.99
10.0
6.2
1.21
1.21
mmol/l
0.07
259
1439
170
759
2.93
25.99
3.1
2.1
—
—
—
0
0
35
46
8.13
25.39
2.4
2.8
—
—
—
0
0
164
737
2.87
24.56
13.3
4.4
—
—
—
0
0
106
374
3.36
24.17
1.5
1.5
—
—
—
0
0
266
1542
2.64
23.79
9.5
6.0
1.20
1.21
mmol/l
0.16
259
1363
65
166
4.38
23.62
1.4
1.5
—
—
—
0
0
291
1769
2.65
23.49
10.0
19.9
1.14
1.41
inr
7.63
54
491
196
995
2.65
22.82
3.4
2.1
—
—
—
0
0
190
968
2.60
21.75
5.2
3.2
7.40
7.40
ph
0.03
28
146
145
653
2.75
21.19
6.2
2.1
2.51
2.43
mmol/l
11.20
133
544
198
1088
2.40
18.64
7.5
2.0
2.36
2.35
mmol/l
0.74
180
887
33
64
5.47
16.51
1.6
1.3
8.16
7.54
u/l
0.13
28
56
14
0
+∞
14.66
8.6
0.0
0.27
—
umol/l
—
14
0
70
269
2.88
13.38
4.6
4.7
7.40
7.38
ph
—
6
26
59
206
3.13
13.35
4.7
4.9
—
—
—
0
0
232
1506
2.05
13.19
3.4
2.4
—
—
—
0
0
24
22
11.42
13.16
1.9
1.3
—
—
—
0
0
243
3220
0.50
12.32
4.8
6.6
40.24
40.94
mmol/mol
0.53
212
2945
50
173
3.11
11.46
5.2
5.7
25.97
24.89
mmol/l
1.50
50
162
93
446
2.35
11.22
10.3
8.2
1.40
1.34
mmol/l
0.06
83
345
52
187
3.00
11.15
16.3
13.7
—
—
—
0
0
335
2565
2.03
11.11
15.9
5.0
85.74
76.25
u/l
4.23
330
2346
258
3313
0.52
11.02
3.5
4.7
1.43
1.40
mmol/l
0.48
221
2992
272
3430
0.52
10.82
3.6
5.4
2.64
2.55
mmol/l
0.96
227
3106
70
300
2.56
10.76
1.5
1.5
—
—
—
0
0
27
66
4.28
10.29
3.0
2.8
—
—
—
0
0
124
693
2.07
10.15
2.1
1.7
2.00
1.47
mg/l
0.96
99
538
265
3347
0.53
10.15
3.4
4.7
4.47
4.35
mmol/l
1.00
229
3047
55
222
2.67
9.52
5.6
3.5
1.67
0.80
%
1.29
35
64
157
972
1.92
9.51
2.7
2.9
0.71
0.37
e6/l
0.73
118
727
283
2107
1.84
9.50
9.0
4.8
6.65
6.86
mmol/l
1.20
275
1972
151
930
1.91
9.25
2.7
2.8
—
—
—
0
0
52
207
2.70
9.24
5.8
3.6
0.21
0.06
%
1.14
33
47
67
304
2.40
9.08
14.7
8.7
—
—
—
0
0
212
1462
1.81
9.01
15.1
7.9
0.00
0.00
e9/l
0.14
157
1178
17
18
9.75
8.84
2.4
1.9
31.56
47.69
%
2.79
17
18
88
454
2.15
8.79
1.7
1.8
—
—
—
0
0
14
10
14.38
8.74
2.1
1.5
0.10
0.18
e9/l
—
14
10
165
1062
1.85
8.73
2.8
3.0
20.24
141.50
e6/l
1.26
125
808
49
195
2.69
8.71
4.9
3.6
0.98
0.62
%
0.52
32
52
74
358
2.26
8.65
1.6
1.6
—
—
—
0
0
21
50
4.35
8.28
2.4
1.8
151.20
12375.92
u/l
—
8
12
28
83
3.52
8.20
1.6
2.0
8.75
12.16
mg/l
1.40
28
76
87
462
2.08
8.03
6.8
5.5
1.03
1.03
mmol/l
0.00
81
415
121
722
1.91
8.01
2.5
2.6
537.58
563.11
mosm/kgh2o
0.67
108
594
127
775
1.87
7.83
5.2
3.9
177.12
336.38
ng/l
0.87
110
646
258
3194
0.58
7.67
3.2
4.2
1.19
1.26
mmol/l
0.95
216
2855
84
450
2.05
7.55
11.6
6.7
103.54
104.68
mmol/l
1.45
84
450
19
33
5.95
7.29
3.8
2.6
1.95
1.41
%
0.19
19
27
70
1240
0.49
7.15
2.2
3.2
8.58
7.65
mmol/l
0.93
57
1034
67
1196
0.49
6.97
2.2
3.3
16.30
190.08
mg/l
1.56
40
781
11
8
14.04
6.92
2.4
1.0
—
—
—
0
0
35
791
0.40
6.75
3.3
4.0
1.02
1.02
kg/l
—
5
116
75
1266
0.52
6.49
2.9
3.9
1.94
9.45
mg/mmol
8.15
39
821
45
199
2.39
6.45
5.5
3.7
0.13
0.02
%
0.75
24
41
53
252
2.24
6.43
1.4
1.5
—
—
—
0
0
10
7
14.55
6.42
1.9
1.7
—
—
—
0
0
10
7
14.55
6.42
1.9
1.7
6.60
6.14
%
—
10
7
10
8
12.73
6.10
2.9
2.0
3.68
5.05
nmol/l
—
10
8
64
337
2.04
5.99
5.8
3.8
—
—
—
0
0
56
282
2.12
5.90
2.5
2.0
34.04
30.88
u/l
0.33
51
232
173
1241
1.62
5.71
3.2
3.2
1067.45
1842.75
ng/l
3.59
160
1073
170
1216
1.62
5.67
3.3
3.5
125.04
86.65
e6/l
0.21
127
860
21
67
3.23
5.53
2.7
2.1
14.84
15.96
%
—
10
35
128
864
1.66
5.33
1.5
1.3
—
—
—
0
0
11
15
7.48
5.17
2.8
1.8
367.09
921.20
e6/l
1.97
11
15
148
1044
1.61
5.14
3.6
2.2
53.45
61.30
u/l
0.91
141
956
70
402
1.87
5.09
1.3
1.3
404.21
581.54
titre
0.67
19
91
291
3370
0.65
4.81
4.3
4.9
6.08
6.10
mmol/l
0.07
252
3020
13
25
5.31
4.80
1.3
1.1
—
—
—
0
0
13
26
5.11
4.66
5.6
3.0
—
—
—
0
0
23
88
2.70
4.46
4.5
2.9
7.43
7.41
ph
1.70
23
75
25
102
2.53
4.29
4.9
3.5
—
—
—
0
0
7
6
11.81
4.29
1.0
1.0
—
—
—
0
0
89
579
1.66
4.20
2.7
2.8
3.09
2.00
e6/l
0.42
44
319
87
572
1.64
3.93
1.9
2.4
9.27
12.82
umol/l
5.92
82
526
33
159
2.16
3.92
1.1
1.2
—
—
—
0
0
75
475
1.69
3.91
1.9
2.5
18.49
23.23
%
2.33
69
404
11
23
4.87
3.89
1.3
1.1
—
—
—
0
0
16
55
2.98
3.77
5.3
2.7
63.38
58.51
%
0.60
16
55
16
55
2.98
3.77
4.2
2.4
4.41
4.46
e9/l
0.04
16
55
12
29
4.22
3.73
1.4
1.2
—
—
—
0
0
9
16
5.71
3.67
6.8
2.7
—
—
—
0
0
127
930
1.50
3.57
3.8
2.6
2598.70
9013.33
umol/l
1.41
114
796
6
6
10.11
3.50
3.0
1.2
62.00
66.67
nmol/l
—
6
6
20
82
2.50
3.43
1.5
2.8
—
—
—
0
0
18
70
2.63
3.42
2.3
2.5
—
—
—
0
0
103
728
1.53
3.41
2.2
2.3
3.80
4.19
e6/l
0.25
94
644
5
5
10.09
2.98
1.4
2.0
—
—
—
0
0
10
27
3.76
2.89
6.4
2.5
—
—
—
0
0
17
365
0.45
2.84
1.9
1.6
—
—
—
0
0
19
84
2.31
2.81
1.9
1.9
121.45
131.52
g/l
0.50
11
61
10
28
3.63
2.80
1.1
1.1
2.05
6.71
nmol/l
—
5
5
12
40
3.05
2.71
2.8
1.4
88.72
90.50
%
0.61
12
40
62
414
1.57
2.64
1.6
1.7
—
—
—
0
0
155
1891
0.73
2.57
4.5
4.1
2.51
2.08
ug/l
0.95
129
1679
32
180
1.83
2.54
5.7
3.7
24.99
24.12
mmol/l
0.64
32
175
135
1679
0.73
2.53
3.2
3.7
0.00
0.00
estimate
-0.00
33
272
133
1658
0.73
2.53
3.2
3.6
0.00
0.00
estimate
0.50
33
302
61
869
0.66
2.43
1.5
1.8
521.35
411.52
pmol/l
1.65
46
704
6
12
5.05
2.41
1.2
1.0
—
—
—
0
0
13
52
2.54
2.38
1.5
1.3
—
—
—
0
0
10
33
3.07
2.37
1.7
1.1
—
—
—
0
0
134
1655
0.74
2.36
4.6
4.9
0.00
0.00
estimate
-0.00
32
276
74
1004
0.69
2.28
2.4
3.3
—
—
—
0
0
14
60
2.37
2.24
1.6
1.5
86.78
64.12
mmol/l
—
9
50
106
1343
0.73
2.17
3.2
3.4
6.19
5.94
ph
—
8
54
353
3788
0.74
2.16
48.2
20.2
124.36
136.07
g/l
30.48
346
3703
353
3787
0.74
2.15
47.6
20.1
7.72
6.89
e9/l
2.87
340
3651
353
3787
0.74
2.15
48.9
20.3
38.08
40.07
%
9.62
329
3456
353
3786
0.74
2.13
47.3
20.0
29.55
30.50
pg
17.09
345
3704
353
3786
0.74
2.13
47.4
20.1
4.27
4.49
e12/l
11.93
340
3643
353
3785
0.74
2.12
47.4
20.1
90.27
91.52
fl
5.58
345
3703
131
1601
0.75
2.09
1.5
2.1
97.13
91.87
pmol/l
0.50
75
840
353
3783
0.74
2.09
47.4
20.1
284.62
236.81
e9/l
17.68
340
3663
11
244
0.44
2.04
1.6
3.0
—
—
—
0
0
283
3120
0.77
2.03
5.6
4.2
2.13
1.98
mu/l
0.52
255
2791
40
257
1.61
2.03
1.2
1.4
—
—
—
0
0
42
274
1.58
2.00
2.4
6.1
—
—
—
0
0
35
218
1.65
2.00
3.3
2.8
5.67
5.67
e9/l
0.00
24
163
16
306
0.51
1.97
1.1
1.3
—
—
—
0
0
68
910
0.71
1.93
3.5
3.9
0.00
0.00
estimate
-0.00
30
266
17
85
2.04
1.92
1.4
1.2
—
—
—
0
0
280
2532
1.26
1.67
4.6
3.9
23.53
12.30
mm/h
9.12
271
2280
5
132
0.37
1.64
23.2
9.9
—
—
—
0
0
62
819
0.72
1.62
2.9
3.7
—
—
—
0
0
5
14
3.60
1.62
1.2
1.0
—
—
—
0
0
77
981
0.74
1.60
1.3
1.6
23.11
19.47
nmol/l
1.18
71
818
11
51
2.18
1.51
1.4
1.6
—
—
—
0
0
6
21
2.88
1.51
2.7
2.7
—
—
—
0
0
6
21
2.88
1.51
1.5
1.2
2.14
2.04
mmol/l
—
6
21
261
2856
0.81
1.49
41.7
18.5
327.30
332.77
g/l
16.22
256
2834
9
37
2.46
1.48
2.6
1.2
—
—
—
0
0
9
37
2.46
1.48
1.4
1.2
—
—
—
0
0
109
1309
0.78
1.45
2.1
2.2
77.23
76.43
nmol/l
0.10
93
1121
63
479
1.36
1.43
2.4
2.0
1.64
1.71
%
0.23
57
420
36
247
1.49
1.42
1.3
1.3
—
—
—
0
0
12
60
2.03
1.39
1.5
1.3
—
—
—
0
0
6
23
2.63
1.37
1.2
1.2
—
—
—
0
0
5
17
2.96
1.36
1.2
2.8
925.60
728.18
u/ml
—
5
17
52
387
1.39
1.35
6.1
3.7
6.19
5.83
kpa
1.04
52
376
171
1495
1.22
1.31
4.4
4.0
34.94
97.98
ng/l
1.15
141
1132
24
156
1.57
1.22
1.1
1.3
62.11
119.19
iu/ml
—
7
65
17
102
1.69
1.17
1.0
1.1
—
—
—
0
0
8
39
2.07
1.15
1.3
1.1
—
—
—
0
0
0
36
0.00
1.14
0.0
1.0
—
323.29
—
0
24
49
630
0.75
1.10
1.3
1.2
1.31
1.52
u/ml
—
7
157
259
2386
1.19
1.08
4.0
4.1
—
—
—
0
0
51
394
1.33
1.08
2.4
2.7
6.87
7.55
ug/l
0.22
43
337
26
178
1.49
1.08
1.1
1.7
1.96
1.50
g/l
1.14
21
151
336
3538
0.83
1.06
28.1
13.4
—
—
—
0
0
9
46
1.97
1.04
1.9
1.4
—
—
—
0
0
7
131
0.53
1.00
1.9
1.4
—
—
—
0
0
24
165
1.48
0.99
4.1
7.0
1.70
1.67
%
0.07
24
159
46
357
1.32
0.96
2.6
2.1
60.26
66.26
e9/l
0.56
31
283
346
3621
0.84
0.94
19.5
8.8
24.91
25.21
u/l
0.12
338
3448
12
70
1.73
0.93
2.3
1.1
—
—
—
0
0
347
3629
0.84
0.93
35.5
17.3
4.01
4.01
mmol/l
0.00
338
3514
10
55
1.84
0.92
1.0
1.2
—
—
—
0
0
125
1096
1.19
0.90
4.7
4.1
—
—
—
0
0
68
816
0.81
0.89
1.6
1.8
1209.53
1155.13
nmol/l
0.15
44
611
347
3624
0.84
0.88
35.3
17.3
138.37
139.77
mmol/l
13.37
339
3509
24
332
0.71
0.88
1.8
3.0
—
—
—
0
0
13
80
1.64
0.85
11.5
3.0
1.15
1.74
mg/l
2.25
13
71
13
80
1.64
0.85
1.2
1.2
—
2.63
—
0
9
36
275
1.33
0.85
3.4
3.2
—
—
—
0
0
13
200
0.64
0.81
1.0
1.3
—
—
—
0
0
13
82
1.60
0.78
2.2
1.3
4.35
4.03
mmol/l
0.24
13
76
7
125
0.55
0.78
2.1
1.9
—
—
—
0
0
61
507
1.23
0.77
1.2
1.3
27.56
41.57
iu/ml
0.55
12
153
17
116
1.48
0.75
1.1
1.2
—
0.23
—
0
12
5
24
2.09
0.74
3.8
4.3
8.60
7.74
mmol/l
—
5
14
74
863
0.83
0.74
3.3
3.2
—
—
—
0
0
68
574
1.22
0.74
1.5
1.2
1.95
2.66
g/l
2.30
46
329
47
381
1.26
0.74
2.0
3.3
183.33
240.00
ng/l
0.73
40
353
7
38
1.85
0.74
1.1
1.2
—
—
—
0
0
5
26
1.93
0.71
2.6
2.5
—
—
—
0
0
22
161
1.38
0.69
4.1
7.2
0.84
0.91
%
0.53
22
155
7
42
1.68
0.68
1.1
1.0
—
—
—
0
0
273
2871
0.89
0.64
41.9
16.1
14.93
15.04
%
0.18
268
2809
14
96
1.47
0.62
2.2
1.3
660.14
528.04
mg/l
0.38
14
91
17
232
0.72
0.61
1.1
1.2
—
—
—
0
0
13
88
1.49
0.61
2.2
1.4
30.37
1487.34
e6/l
—
8
77
13
88
1.49
0.61
2.3
1.3
41.88
87.86
e6/l
—
8
76
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
0
23
0.00
0.58
0.0
3.2
—
30.53
—
0
15
234
2470
0.90
0.56
5.0
3.4
15.10
14.92
pmol/l
0.46
218
2193
6
38
1.59
0.54
1.0
1.2
—
—
—
0
0
9
61
1.48
0.54
2.9
2.6
—
—
—
0
0
56
485
1.18
0.50
1.2
1.3
31.78
14.69
u/ml
0.33
12
171
7
48
1.47
0.47
2.1
5.8
6.74
7.62
mmol/l
—
7
37
106
971
1.12
0.44
1.9
2.1
3.52
3.03
mg/l
1.10
92
819
5
31
1.62
0.43
1.4
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
11.5
—
0.64
—
0
15
0
15
0.00
0.41
0.0
1.0
—
34.50
—
0
8
213
2027
1.09
0.41
4.5
2.9
59.35
48.28
u/l
0.88
203
1850
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
5
34
1.48
0.40
1.4
1.5
—
—
—
0
0
0
18
0.00
0.40
0.0
12.9
—
817.00
—
0
18
0
18
0.00
0.40
0.0
17.1
—
1461.39
—
0
18
15
115
1.31
0.39
4.1
4.1
—
—
—
0
0
0
19
0.00
0.39
0.0
3.6
—
—
—
0
0
24
197
1.23
0.38
1.5
1.3
—
—
—
0
0
5
36
1.39
0.38
1.2
1.3
—
—
—
0
0
257
2472
1.09
0.38
3.9
4.2
—
—
—
0
0
16
125
1.29
0.37
1.3
1.2
—
—
—
0
0
22
267
0.82
0.37
2.4
4.1
93.07
102.07
ng/l
0.11
15
231
26
310
0.83
0.37
1.7
2.1
158.60
185.23
ug/g
0.21
21
240
351
3423
1.10
0.37
37.5
13.8
44.30
26.31
mg/l
11.65
334
2651
13
168
0.77
0.36
1.3
1.4
—
—
—
0
0
5
80
0.62
0.35
1.2
1.1
—
65.71
—
0
7
17
211
0.80
0.35
4.2
3.4
—
—
—
0
0
14
178
0.78
0.35
1.5
1.2
144.35
199.38
u/ml
0.37
14
163
15
188
0.79
0.34
2.3
2.3
—
—
—
0
0
11
83
1.33
0.32
3.6
11.5
103.55
105.46
mmol/l
0.73
11
78
11
83
1.33
0.32
3.6
11.5
10.27
11.64
mmol/l
0.65
11
78
11
84
1.32
0.30
1.3
1.1
—
—
—
0
0
10
76
1.32
0.28
6.5
3.2
—
—
—
0
0
8
63
1.27
0.28
7.9
2.5
63.50
63.91
%
—
8
63
17
140
1.22
0.28
1.8
1.8
—
—
—
0
0
36
320
1.14
0.26
8.0
3.3
5.12
4.48
kpa
0.60
36
308
9
72
1.25
0.25
2.4
1.4
—
—
—
0
0
10
127
0.78
0.25
1.6
2.5
0.27
0.24
g/l
—
5
39
14
170
0.82
0.25
3.9
4.7
—
—
—
0
0
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
7.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
3.28
—
0
6
0
13
0.00
0.21
0.0
1.5
—
1.43
—
0
13
0
14
0.00
0.20
0.0
2.4
—
43114.29
—
0
14
11
90
1.23
0.19
1.5
1.2
—
—
—
0
0
17
195
0.87
0.18
3.1
2.8
0.28
0.21
e6/l
0.24
17
189
102
1052
0.96
0.11
2.6
3.1
—
—
—
0
0
5
44
1.14
0.10
1.2
1.5
—
—
—
0
0
10
87
1.15
0.09
2.1
1.6
—
—
—
0
0
101
1037
0.97
0.09
3.1
2.8
0.90
0.76
ug/l
0.62
72
725
5
63
0.79
0.08
1.0
1.1
24.76
22.69
u/l
—
5
55
142
1393
1.03
0.08
2.6
2.7
410.08
140.51
ug/l
3.39
133
1260
6
73
0.82
0.07
1.0
1.5
—
—
—
0
0
44
427
1.03
0.04
1.1
1.2
—
—
—
0
0
11
105
1.05
0.00
2.5
1.4
39.89
56.07
mg/l
0.61
11
89
11
106
1.04
0.00
2.5
1.4
30.75
39.37
mg/l
0.45
11
91
21
212
0.99
0.00
1.3
1.6
—
—
—
0
0
25
248
1.01
0.00
2.0
1.9
0.17
0.20
g/l
1.50
25
220
5
49
1.02
0.00
1.2
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.4
—
8.38
—
0
7
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
9
90
1.00
-0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
71.40
—
0
5
0
9
0.00
-0.00
0.0
8.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
7
70
1.00
-0.00
1.3
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
7.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
37.8
—
8.02
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
170.33
—
0
6

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_HEART_MEDIASTINUM_PLEURA – Malignant neoplasm of heart, mediastinum and pleura

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).